rs469083
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002462.5(MX1):c.299-226C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 152,002 control chromosomes in the GnomAD database, including 27,924 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 27924 hom., cov: 32)
Consequence
MX1
NM_002462.5 intron
NM_002462.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.335
Publications
7 publications found
Genes affected
MX1 (HGNC:7532): (MX dynamin like GTPase 1) This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.663 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MX1 | NM_002462.5 | c.299-226C>T | intron_variant | Intron 6 of 16 | ENST00000398598.8 | NP_002453.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MX1 | ENST00000398598.8 | c.299-226C>T | intron_variant | Intron 6 of 16 | 1 | NM_002462.5 | ENSP00000381599.3 |
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91177AN: 151884Hom.: 27891 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
91177
AN:
151884
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.600 AC: 91274AN: 152002Hom.: 27924 Cov.: 32 AF XY: 0.596 AC XY: 44266AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
91274
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
44266
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
22339
AN:
41432
American (AMR)
AF:
AC:
9059
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1641
AN:
3466
East Asian (EAS)
AF:
AC:
1456
AN:
5176
South Asian (SAS)
AF:
AC:
2480
AN:
4820
European-Finnish (FIN)
AF:
AC:
6808
AN:
10562
Middle Eastern (MID)
AF:
AC:
156
AN:
292
European-Non Finnish (NFE)
AF:
AC:
45409
AN:
67952
Other (OTH)
AF:
AC:
1233
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1847
3694
5540
7387
9234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1336
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.